News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 


Medicine Recall – Marevan® (Warfarin) 3mg Tablets

Medicine Recall – Marevan® (Warfarin) 3mg Tablets (Blue)


Recall of Marevan® (warfarin) 3mg tablets (blue)
GlaxoSmithKline New Zealand (GSK), in consultation with Medsafe, is recalling all Marevan (warfarin) 3mg tablets (blue) dispensed to patients since 23 November 2009.
Marevan® is an anticoagulant treatment used widely in New Zealand to thin blood to help prevent blood clots. Marevan® 3mg tablets are blue in colour.
The recall is due to a manufacturing problem that could mean that a limited number of the Marevan® (warfarin) 3mg tablets (blue) may contain more medicine than the labelled amount.

If a patient has taken a Marevan ® (warfarin) 3mg tablet (blue) from the affected batch, it may place the patient at an increased risk of bruising and/or bleeding. Signs of increased anticoagulant activity include abnormal bleeding or bruising, vomiting with the appearance of coffee grounds or blood, blood in the urine or stool, or black tarry stools.
Patients who have received their Marevan® 3mg tablets (blue) after 23 November 2009 are advised to:

1. Not suddenly stop taking this treatment.

2. Seek advice and replacement tablets as soon as possible.

3. Return the Marevan® (warfarin) 3mg tablets (blue) to their pharmacy for free replacement, if required.

4. Contact the doctor or clinic that prescribed their medicine for advice on whether further testing or monitoring is required.

5. Contact their doctor immediately if any ill effects are noticed.


GSK is working with doctors and pharmacists to contact any patients who may be affected by this batch recall.
“Patient safety is our first concern and the results of our investigations to date give us confidence that this is an isolated incident. If patients have any concerns about their medication, they should discuss these with their pharmacist or their health practitioner,” said Geoff McDonald, General Manager at GSK New Zealand.
Marevan® (warfarin) is available in three different strengths – 1mg (brown), 3mg (blue) and 5mg (pink). This recall only affects the Marevan® (warfarin) 3mg tablets (blue) and does not affect any other batches or strengths, or any other GSK products.

GSK sincerely regrets any inconvenience and is confident that supply to customers will not be affected by this recall activity.

ENDS

© Scoop Media

 
 
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 

Book Awards: Jill Trevelyan's Story Of Peter McLeavey Is Book Of The Year

The story of Wellington art dealer Peter McLeavey and his gallery has won the prestigious New Zealand Post Book of the Year 2014 in a glittering ceremony in Wellington. More>>

ALSO:

Scoop Review Of Books: King Richard

Simon Nathan reviews 'Richard Seddon, King of God’s Own': My father grew up in Wellington during Seddon’s premiership... I can recall him standing under the Seddon statue in the grounds of parliament and telling me that Seddon had more backbone than Sid Holland and all his cabinet colleagues put together.. More>>

8 October: Miley Cyrus Bangerz Tour Coming To Auckland!

Dainty Group announced today that global superstar Miley Cyrus will bring her BANGERZ TOUR to New Zealand in October this year. This will be Miley’s first ever visit to New Zealand and there will only be one Auckland show before she takes her tour to Australia. More>>

ALSO:

Music: Lorde NZ Tour Confirmed In Four Major Cities!

In what will be her first ever New Zealand headline tour, Frontier Touring and Brent Eccles Entertainment are stoked to bring you four epic shows across the country! The all ages concerts take place late October/ early November in Christchurch, Dunedin, Wellington and Auckland. More>>

ALSO:

Scoop Review Of Books: Poor Economics

A review of and excerpt from Jonathan Boston and Simon Chapple’s Child Poverty in New Zealand. More>>

Head Count: Highest Population Growth Since 2003

The country’s population grew by 67,800 people, or 1.5 percent, in the year to 30 June 2014. This came from natural increase (births minus deaths) of 29,500 and net migration (arrivals minus departures) of 38,300. New Zealand's estimated resident population was 4.51 million at 30 June 2014. More>>

Fun-Enhancement: Research To Ensure Even Game For Less Skilled Players

A University of Canterbury engineering PhD student is researching sports, such as table tennis, to ensure closer games for both better and less skilled players. More>>

Werewolf: From The Lost Continent

It’s a case of better late than never for Olivier Assayas’ marvellous After May/Apres Mai, which first screened at Venice in 2012, got a theatrical release in Australia – but not here – and only now appears on DVD, after Assayas himself has moved on. More>>

ALSO:

Werewolf: Blue Eyed & Soulful

Last year’s Muscle Shoals documentary was a reminder that on some of soul music’s most hallowed tracks, the studio band consisted of a bunch of white guys from rural Alabama... More>>

ALSO:

Get More From Scoop

 
 

LATEST HEADLINES

 
 
 
 
Health
Search Scoop  
 
 
Powered by Vodafone
NZ independent news